Page 9 - 22-0424

The International Journal of the Royal Society of Thailand
Volume XI - 2019

Acknowledgments

The author’s research was supported by grants from Mahidol University—
Multidisciplinary Research Cluster Grant, the National Research Council of
Thailand (NRCT) and National Science and Technology Development Agency
(NSTDA).

References
Chanpaisaeng K, Teerapornpuntakit J, Wongdee K, Charoenphandhu N.
Emerging roles of calcium-sensing receptor in the local regulation of
intestinal transport of ions and calcium. American Journal of Physiology–
Cell Physiology 2021;320(3):C270–C278.

Davies AJ. Radioimmunotherapy for B-cell lymphoma: Y ibritumomab tiuxetan
90
and I (131) tositumomab. Oncogene. 2007;26(25):3614–3628.

Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, et al. Efficacy and
safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with
RPE65-mediated inherited retinal dystrophy: a randomised, controlled,
open-label, phase 3 trial. Lancet. 2017;390(10097):849–860.

Zhang X, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Ito T, et al. Pharmacokinetics
and pharmacodynamics of a human monoclonal anti-FGF23 antibody
(KRN23) in the first multiple ascending-dose trial treating adults with
X-linked hypophosphatemia. Journal of Clinical Pharmacology. 2016;
56(2):176–185.

Narattaphol Charoenphandhu 3

11/7/2565 BE 13:26
_22-0424(001-004)1.indd 3 11/7/2565 BE 13:26
_22-0424(001-004)1.indd 3